Araki, H., Yamamoto, T., Kobayashi, Y., Futagami, K., Kawasaki, H., & Gomita, Y. (2002). Effect of methamphetamine and imipramine on cerebral ischemia-induced hyperactivity in Mongolian gerbils. Japanese Journal of Pharmacology, 88(3), 293–299.

Article  CAS  PubMed  Google Scholar 

Ascano, M., Mukherjee, N., Bandaru, P., Miller, J. B., Nusbaum, J. D., Corcoran, D. L., et al. (2012). FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature, 492(7429), 382–386.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Babovic, D., O’Tuathaigh, C. M., O’Sullivan, G. J., Clifford, J. J., Tighe, O., Croke, D. T., et al. (2007). Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice. Behavioural Brain Research, 183(2), 236–239.

Article  CAS  PubMed  Google Scholar 

Bowers, M. E., Buzzell, G. A., Salo, V., Troller-Renfree, S. V., Hodgkinson, C. A., Goldman, D., et al. (2020). Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhood. Developmental Psychobiology, 62(2), 181–190.

Article  CAS  PubMed  Google Scholar 

Craddock, N., Owen, M. J., & O’Donovan, M. C. (2006). The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: Evidence and lessons. Molecular Psychiatry, 11(5), 446–458.

Article  CAS  PubMed  Google Scholar 

Crawford, H., Scerif, G., Wilde, L., Beggs, A., Stockton, J., Sandhu, P., et al. (2021). Genetic modifiers in rare disorders: The case of fragile X syndrome. European Journal of Human Genetics, 29(1), 173–183. https://doi.org/10.1038/s41431-020-00711-x

Article  CAS  PubMed  Google Scholar 

Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., et al. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. https://doi.org/10.1016/j.cell.2011.06.013

Article  PubMed  PubMed Central  Google Scholar 

Davidson, M., Sebastian, S. A., Benitez, Y., Desai, S., Quinonez, J., Ruxmohan, S., et al. (2022). Behavioral problems in fragile X syndrome: A review of clinical management. Cureus. https://doi.org/10.7759/cureus.21840

Article  PubMed  PubMed Central  Google Scholar 

Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006). The quantification of COMT mRNA in post mortem cerebellum tissue: Diagnosis, genotype, methylation and expression. BMC Medical Genetics, 7, 1–7.

Article  Google Scholar 

Ding, Q., Sethna, F., & Wang, H. (2014). Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background. Behavioural Brain Research, 271, 72–78. https://doi.org/10.1016/j.bbr.2014.05.046

Article  CAS  PubMed  Google Scholar 

Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the USA, 95(17), 9991–9996.

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Castro, T. B., Hernández-Díaz, Y., Juárez-Rojop, I. E., López-Narváez, M. L., Tovilla-Zárate, C. A., & Fresan, A. (2016). The role of a catechol-O-methyltransferase (COMT) Val158Met genetic polymorphism in schizophrenia: A systematic review and updated meta-analysis on 32,816 subjects. NeuroMolecular Medicine, 18(2), 216–231.

Article  PubMed  Google Scholar 

Gothelf, D., Law, A. J., Frisch, A., Chen, J., Zarchi, O., Michaelovsky, E., et al. (2014). Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome. Biological Psychiatry, 75(5), 406–413. https://doi.org/10.1016/j.biopsych.2013.07.021

Article  CAS  PubMed  Google Scholar 

Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., et al. (2017). Fragile X syndrome. Nature Reviews Disease Primers, 3, 1–19.

Article  Google Scholar 

Li, M., Shin, J., Risgaard, R. D., Parries, M. J., Wang, J., Chasman, D., et al. (2020). Identification of FMR1-regulated molecular networks in human neurodevelopment. Genome Research, 30(3), 361–374.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma, J., Zhao, M., Zhou, W., Li, M., Huai, C., Shen, L., et al. (2020). Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: An updated meta-analysis. Current Neuropharmacology, 19(10), 1780–1790.

Article  Google Scholar 

Maurin, T., Lebrigand, K., Castagnola, S., Paquet, A., Jarjat, M., Popa, A., et al. (2018). HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein. Nucleic Acids Research, 46(12), 6344–6355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pálmason, H., Moser, D., Sigmund, J., Vogler, C., Hänig, S., Schneider, A., et al. (2010). Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. Journal of Neural Transmission, 117(2), 259–267.

Article  PubMed  Google Scholar 

Papaleo, F., Crawley, J. N., Song, J., Lipska, B. K., Pickel, J., Weinberger, D. R., et al. (2008). Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. The Journal of Neuroscience, 28(35), 8709–8723.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soeiro-De-Souza, M. G., Stanford, M. S., Bio, D. S., Machado-Vieira, R., & Moreno, R. A. (2013). Association of the COMT met158 allele with trait impulsivity in healthy young adults. Molecular Medicine Reports, 7(4), 1067–1072.

Article  CAS  PubMed  Google Scholar 

Tammimäki, A., Käenmäki, M., Kambur, O., Kulesskaya, N., Keisala, T., Karvonen, E., et al. (2010). Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice. Psychopharmacology (berl), 211(4), 389–401.

Article  PubMed  Google Scholar 

Taylor, S. (2018). Association between COMT Val158Met and psychiatric disorders: A comprehensive meta-analysis. American Journal of Medical Genetics Part B, 177(2), 199–210.

Article  CAS  Google Scholar 

Turner, G., & Fragile, X. (1997). Syndrome: diagnosis, treatment and research. Journal of Medical Genetics. https://doi.org/10.1136/jmg.34.5.439

Article  PubMed  PubMed Central  Google Scholar 

Utami, K. H., Skotte, N. H., Colaço, A. R., Yusof, N. A. B. M., Sim, B., Yeo, X. Y., et al. (2020a). Integrative analysis identifies key molecular signatures underlying neurodevelopmental deficits in fragile X syndrome. Biological Psychiatry, 88(6), 500–511.

Article  CAS  PubMed  Google Scholar 

Utami, K. H., Yusof, N. A. B. M., Kwa, J. E., Peteri, U. K., Castrén, M. L., & Pouladi, M. A. (2020b). Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment. Molecular Autism, 11(1), 1–11.

Article  Google Scholar